Dimension Therapeutics Receives $65,000,000 Series B Funding Round

  • Feed Type
  • Date
    4/21/2015
  • Company Name
    Dimension Therapeutics
  • Mailing Address
    840 Memorial Drive 4th Floor Cambridge, MA 02139 USA
  • Company Description
    Dimension Therapeutics is a gene therapy company focused on developing novel treatments for rare diseases. The company was launched in 2013 by Fidelity Biosciences and REGENX Biosciences. Dimension has now raised $30M with funding from Fidelity Biosciences and OrbiMed.
  • Website
    http://www.dimensiontx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $65,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Dimension plans to use the proceeds from the financing to further advance the company’s adeno-associated virus (AAV) platform and growing pipeline of gene therapy programs.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy